In 2007, a case between Insmed and Tercica was settled when the jury found that Insmed infringed patents licensed to Tercica for Increlex.
In 2007, a conflict between Insmed and Tercica was resolved when the jury found that Insmed had infringed upon patents licensed to Tercica for Increlex.